Latest Neurotech International (ASX:NTI) News
Page 2
Page 2 of 4
Healthcare Wrap - Week 29 (13 July -> 17 July) 2026
18 July 2026
Neurotech Secures $3.15 Million Loan Backed by R&D Tax Incentives for Phase III Trials
15 July 2026
US FDA Clears IND for Neurotech’s NTI164, Paving Way for US Trials
14 July 2026
Healthcare Wrap - Week 27 (29 June -> 3 July) 2026
4 July 2026
Neurotech Secures US Patent Allowances for NTI164, Extending Protection to 2042
2 July 2026
Healthcare Wrap - Week 18 (27 Apr -> 1 May) 2026
2 May 2026
Neurotech Advances Phase 3 Autism Trial and Reports Strong Safety Data for NTI164
29 Apr 2026
Market Wrap - Week 12 (16 Mar -> 20 Mar) 2026
21 Mar 2026
Healthcare Wrap - Week 12 (16 Mar -> 20 Mar) 2026
21 Mar 2026
Neurotech Launches Phase 3 Trial Site for Autism Treatment NTI164
17 Mar 2026
Healthcare Wrap - Week 9 (23 Feb -> 27 Feb) 2026
28 Feb 2026
Neurotech Slashes Loss, Advances NTI164 with Key Trials and Funding Boost
26 Feb 2026